961 related articles for article (PubMed ID: 33507135)
1. CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW.
Ruiz García Y; Nieto Guevara J; Izurieta P; Vojtek I; Ortega-Barría E; Guzman-Holst A
Expert Rev Vaccines; 2021 Jan; 20(1):45-57. PubMed ID: 33507135
[TBL] [Abstract][Full Text] [Related]
2. Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review.
Singh J; Sundaresan S; Manoharan A; Shet A
Vaccine; 2017 Aug; 35(35 Pt B):4501-4509. PubMed ID: 28711387
[TBL] [Abstract][Full Text] [Related]
3. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
[TBL] [Abstract][Full Text] [Related]
4. Streptococcus pneumoniae serotype 19A: worldwide epidemiology.
Isturiz R; Sings HL; Hilton B; Arguedas A; Reinert RR; Jodar L
Expert Rev Vaccines; 2017 Oct; 16(10):1007-1027. PubMed ID: 28783380
[TBL] [Abstract][Full Text] [Related]
5. Rise of multidrug-resistant Streptococcus pneumoniae clones expressing non-vaccine serotypes among children following introduction of the 10-valent pneumococcal conjugate vaccine in Bulgaria.
Setchanova L; Alexandrova A; Pencheva D; Sirakov I; Mihova K; Kaneva R; Mitov I
J Glob Antimicrob Resist; 2018 Dec; 15():6-11. PubMed ID: 29803821
[TBL] [Abstract][Full Text] [Related]
6. Serotype changes and antimicrobial nonsusceptibility rates of invasive and non-invasive Streptococcus pneumoniae isolates after implementation of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Bulgaria.
Setchanova L; Murdjeva M; Stancheva I; Alexandrova A; Sredkova M; Stoeva T; Yoneva M; Kurchatova A; Mitov I
Braz J Infect Dis; 2017; 21(4):433-440. PubMed ID: 28472614
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
[TBL] [Abstract][Full Text] [Related]
8. The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review.
Tin Tin Htar M; van Den Biggelaar AHJ; Sings H; Ferreira G; Moffatt M; Hall-Murray C; Verstraeten T; Gessner BD; Schmitt HJ; Jodar L
Expert Rev Vaccines; 2019 Oct; 18(10):1069-1089. PubMed ID: 31585049
[No Abstract] [Full Text] [Related]
9. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
Dagan R
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
[TBL] [Abstract][Full Text] [Related]
10. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
[TBL] [Abstract][Full Text] [Related]
11. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016.
Zhao C; Li Z; Zhang F; Zhang X; Ji P; Zeng J; Hu B; Hu Z; Liao K; Sun H; Zhang R; Cao B; Zhuo C; Jia W; Mei Y; Chu Y; Xu X; Yang Q; Jin Y; Fu Q; Xu X; Li H; Wang L; Ni Y; Liang H; Wang H
BMC Infect Dis; 2017 Dec; 17(1):804. PubMed ID: 29284419
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
Shibl AM; Memish ZA; Al-Kattan KM
Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study.
Lo SW; Gladstone RA; van Tonder AJ; Lees JA; du Plessis M; Benisty R; Givon-Lavi N; Hawkins PA; Cornick JE; Kwambana-Adams B; Law PY; Ho PL; Antonio M; Everett DB; Dagan R; von Gottberg A; Klugman KP; McGee L; Breiman RF; Bentley SD;
Lancet Infect Dis; 2019 Jul; 19(7):759-769. PubMed ID: 31196809
[TBL] [Abstract][Full Text] [Related]
14. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.
Pai R; Moore MR; Pilishvili T; Gertz RE; Whitney CG; Beall B;
J Infect Dis; 2005 Dec; 192(11):1988-95. PubMed ID: 16267772
[TBL] [Abstract][Full Text] [Related]
15. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.
Camilli R; D'Ambrosio F; Del Grosso M; Pimentel de Araujo F; Caporali MG; Del Manso M; Gherardi G; D'Ancona F; Pantosti A;
Vaccine; 2017 Aug; 35(35 Pt B):4587-4593. PubMed ID: 28716556
[TBL] [Abstract][Full Text] [Related]
16. Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil.
Cassiolato AP; Almeida SCG; Andrade AL; Minamisava R; Brandileone MCC
PLoS One; 2018; 13(11):e0208211. PubMed ID: 30496296
[TBL] [Abstract][Full Text] [Related]
17. Serotypes and antibiotic resistance of non-invasive Streptococcus pneumoniae circulating in pediatric hospitals in Moscow, Russia.
Mayanskiy N; Alyabieva N; Ponomarenko O; Lazareva A; Katosova L; Ivanenko A; Kulichenko T; Namazova-Baranova L; Baranov A
Int J Infect Dis; 2014 Mar; 20():58-62. PubMed ID: 24462930
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Streptococcus pneumoniae serotype 19A isolates from children in the pre and post Conjugate Vaccine Era. Single center experience 1986-2015.
Koutouzis EI; Daikos GL; Chatzichristou P; Michos AG; Koutouzi FI; Chrousos GP; Syriopoulou VP
Vaccine; 2018 Aug; 36(35):5245-5250. PubMed ID: 30061027
[TBL] [Abstract][Full Text] [Related]
19. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.
Moore MR; Gertz RE; Woodbury RL; Barkocy-Gallagher GA; Schaffner W; Lexau C; Gershman K; Reingold A; Farley M; Harrison LH; Hadler JL; Bennett NM; Thomas AR; McGee L; Pilishvili T; Brueggemann AB; Whitney CG; Jorgensen JH; Beall B
J Infect Dis; 2008 Apr; 197(7):1016-27. PubMed ID: 18419539
[TBL] [Abstract][Full Text] [Related]
20. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.
Pelton SI; Huot H; Finkelstein JA; Bishop CJ; Hsu KK; Kellenberg J; Huang SS; Goldstein R; Hanage WP
Pediatr Infect Dis J; 2007 Jun; 26(6):468-72. PubMed ID: 17529860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
